![Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901](https://oncodaily.com/pub/uploads/2023/10/feat.jpg)
Photo taken from Sumanta K. Pal/Twitter
Oct 27, 2023, 04:48
Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901
Sumanta K. Pal, Co-Director of the City of Hope Kidney Cancer Program, posted on Twitter:
“Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901. Loved the fact that she offered a strong, definitive opinion on the “winner” in the battle between these options. Also (not shown) great outline of remaining questions – what comes after EVP? “
Source: Sumanta K. Pal/Twitter
Aug 29, 2024, 17:06